Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
27/09/202414:52UK RegulatoryInformation on the shares issued by Rokiskio suris AB and the votes grantedLSE:0J1SRokiskio Suris Ab
27/09/202414:51PR Newswire (US)Phase 1 clinical trial results support feasibility and safety of administering cell therapy as treatment for people with Parkinson's disease
27/09/202414:45UK RegulatoryBUYBACK OF RIKSBANK CERTIFICATES
27/09/202414:45PR Newswire (US)Law Offices of Jason Turchin Investigates Electric Blanket Recalls Following Fire Hazards and Burn Injuries
27/09/202414:42PR Newswire (US)Surety One, Inc. Backs The Me Fine Foundation, Strengthening The Families of Critically Ill Children
27/09/202414:41UK RegulatoryAcceleration of EVIG’s European Rollout: Clean Motion and Valeo Deepen Collaboration at Valeo New Mobility Center in Amiens
27/09/202414:40UK RegulatoryRightmove Plc - Statement re further proposal from REALSE:RMVRightmove Plc
27/09/202414:40UK RegulatorySamson Rock Capital LLP - Form 8.3 - Ascential PlcLSE:ASCLAscential Plc
27/09/202414:39UK RegulatoryVow ASA: Notification of trade – primary insiderTG:213Vow ASA
27/09/202414:39UK RegulatorySamson Rock Capital LLP - Form 8.3 - Tritax Eurobox PlcLSE:BOXETritax Eurobox Plc
27/09/202414:38UK RegulatoryRokiskio suris AB acquires own sharesLSE:0J1SRokiskio Suris Ab
27/09/202414:38UK RegulatorySamson Rock Capital LLP - Form 8.3 - SEGRO PLCLSE:SGROSegro Plc
27/09/202414:37UK RegulatorySamson Rock Capital LLP - Form 8.3 - Virgin Money UK plcLSE:VMUKVirgin Money Uk Plc
27/09/202414:35UK RegulatoryPress Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDTG:SNWSanofi
27/09/202414:35UK RegulatoryCommuniqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCOEU:SANSanofi
27/09/202414:35UK RegulatoryCommuniqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCOBIT:1SANSanofi
27/09/202414:35UK RegulatoryPress Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDBIT:SANFSanofi
27/09/202414:35UK RegulatoryPress Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDEU:SANSanofi
27/09/202414:35UK RegulatoryPress Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDBIT:1SANSanofi
27/09/202414:35UK RegulatoryCommuniqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCOTG:SNWSanofi
27/09/202414:35UK RegulatoryCommuniqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCOBIT:SANFSanofi
27/09/202414:30Alliance NewsAlliance NewsGermany confirms Biden visit and Ukraine allies meeting
27/09/202414:30PR Newswire (US)GAHL ANNOUNCES STRATEGIC AND FINANCIALLY ACCRETIVE ACQUISITION
27/09/202414:30UK RegulatoryCohen & Steers Capital Management - Form 8.3 - SEGRO plcLSE:SGROSegro Plc
27/09/202414:29PR Newswire (US)BetterHelp Partners with Talkiatry to Offer Therapy & Psychiatric Services to Businesses
27/09/202414:28UK RegulatoryGlobal Opportunities Trust Plc - Net Asset Value(s)LSE:GOTGlobal Opportunities Trust Plc
27/09/202414:27Alliance NewsAlliance NewsFOREX MARKET: Dollar weakens after US data; yen jumps after Ishiba win
27/09/202414:27UK RegulatoryForm 8.3 - Rightmove PlcLSE:RATRathbones Group Plc
27/09/202414:26Alliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:TECHTechfinancials Inc
27/09/202414:26Alliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:GLRGalileo Resources Plc

Your Recent History

Delayed Upgrade Clock